Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability-Reference-Cited by-同舟云学术

Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability

Published:2020-05-18 Issue:13 Volume:21 Page:1808-1815
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

Maguregui Ander¹,Abe Hiroshi²^ORCID

Affiliation:

1. Bioorganic Chemistry Laboratory Graduate School of Science Nagoya University Chikusa-ku Nagoya Aichi 464-0813 Japan

2. Bioorganic Chemistry Laboratory Graduate School of Science Nagoya University Chikusa-Ku Nagoya Aichi 464-8602 Japan

Funder

Japan Agency for Medical Research and Development

Japan Science and Technology Agency

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbic.202000009

Reference60 articles.

1. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

2. siRNA-nanoparticle conjugate in gene silencing: A future cure to deadly diseases?

3. Overcoming cellular barriers for RNA therapeutics

4. Lipid-based vectors for siRNA delivery

5. U.S. Food and Drug Administration 2019 https://www.fda.gov/news-events/press-announcements/fda-approves-first-its-kind-targeted-rna-based-therapy-treat-rare-disease (assessed November 2019).

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the role of siRNA in anxiety and depression;European Journal of Pharmacology;2024-10

2. Unlocking ocular therapy: Harnessing the power of non-coding RNAs;Journal of Drug Delivery Science and Technology;2024-09

3. Kidney targeted delivery of siRNA mediated by peptide-siRNA conjugate for the treatment of acute kidney injury;Chinese Chemical Letters;2024-07

4. Influence of Combinations of Lipophilic and Phosphate Backbone Modifications on Cellular Uptake of Modified Oligonucleotides;Molecules;2024-01-17

5. Overcoming delivery barriers for RNA therapeutics in the treatment of rheumatoid arthritis;European Journal of Pharmaceutics and Biopharmaceutics;2023-11